Patients Seek Calif. MDL In Suits Over Diabetes Drugs
Law360, Miami (January 25, 2018, 5:46 PM EST) -- Diabetes patients suing Bristol-Myers Squibb Co. and AstraZeneca Pharmaceuticals LP over diabetes drugs Onglyza and Kombiglyze told the U.S. Judicial Panel on Multidistrict Litigation in Miami Thursday that coordination on discovery has not worked well so far and asked to consolidate their cases in the Northern District of California.
Timothy Clark of Sanders Phillips Grossman LLC, who represents one group of plaintiffs, said the cases share the same defendants, the same theory of liability and the same basic allegations and should be consolidated before U.S. District Judge Jon S. Tigar in San Francisco, who has already issued a few orders, including...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!